Literature DB >> 28802373

Clinical curative effect and safety of balloon sinuplasty in children with chronic rhinosinusitis.

Jia Liu1, Zigai Zhao1, Yang Chen1, Bin Xu1, Jiren Dai1, Yong Fu2.   

Abstract

OBJECTIVE: Balloon Sinuplasty for the management of paranasal sinus inflammatory diseases was introduced in otolaryngology in 2005. Over the past decade, evidence strongly supports its safety and efficacy for the treatment of chronic rhinosinusitis (CRS) in adults. Because it requires no bone or tissue removal, this procedure could be suitable in children. We present our initial experience of its use for the treatment of CRS in children.
MATERIALS AND METHODS: A prospective study was performed of 30 children with failed medical therapy, who were scheduled for surgery. They underwent treatment by balloon sinuplasty of selected sinuses. Data were collected, including age, VAS score, CT score, and nasal endoscopy findings.
RESULTS: The procedure was successful in 61/65 sinuses (93.84%). Balloon sinuplasty improved sinus-related quality of life scores as well as computed tomography (CT) and endoscopic findings for up to 1 year after operation (p < 0.05).
CONCLUSION: In this initial study, balloon sinuplasty showed a clinical curative effect in the treatment of children with refractory CRS, and was relatively safe. Structural abnormalities in sinus ostia and hypoplastic sinuses may not be amenable to balloon catheter sinuplasty.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Balloon sinuplasty; Children; Chronic rhinosinusitis

Mesh:

Year:  2017        PMID: 28802373     DOI: 10.1016/j.ijporl.2017.06.026

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

1.  Frontal Balloon Sinuplasty in Complicated Acute Pediatric Rhinosinusitis (ARS).

Authors:  Smrithi Chidambaram; Benjamin M Wahle; David S Leonard
Journal:  Case Rep Otolaryngol       Date:  2022-05-14

2.  Chronic Rhinosinusitis in Children.

Authors:  Lourdes Quintanilla-Dieck; Derek J Lam
Journal:  Curr Treat Options Pediatr       Date:  2018-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.